The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry

Peter J Kahrilas, Guy Boeckxstaens, Peter J Kahrilas, Guy Boeckxstaens

Abstract

High-resolution manometry and recently described analysis algorithms, summarized in the Chicago Classification, have increased the recognition of achalasia. It has become apparent that the cardinal feature of achalasia, impaired lower esophageal sphincter relaxation, can occur in several disease phenotypes: without peristalsis, with premature (spastic) distal esophageal contractions, with panesophageal pressurization, or with peristalsis. Any of these phenotypes could indicate achalasia; however, without a disease-specific biomarker, no manometric pattern is absolutely specific. Laboratory studies indicate that achalasia is an autoimmune disease in which esophageal myenteric neurons are attacked in a cell-mediated and antibody-mediated immune response against an uncertain antigen. This autoimmune response could be related to infection of genetically predisposed subjects with herpes simplex virus 1, although there is substantial heterogeneity among patients. At one end of the spectrum is complete aganglionosis in patients with end-stage or fulminant disease. At the opposite extreme is type III (spastic) achalasia, which has no demonstrated neuronal loss but only impaired inhibitory postganglionic neuron function; it is often associated with accentuated contractility and could be mediated by cytokine-induced alterations in gene expression. Distinct from these extremes is progressive plexopathy, which likely arises from achalasia with preserved peristalsis and then develops into type II achalasia and then type I achalasia. Variations in its extent and rate of progression are likely related to the intensity of the cytotoxic T-cell assault on the myenteric plexus. Moving forward, we need to integrate the knowledge we have gained into treatment paradigms that are specific for individual phenotypes of achalasia and away from the one-size-fits-all approach.

Keywords: Achalasia; Dysphagia; EGJ; EPT; Esophageal Motility; HSV-1; IRP; LES; Pathogenesis; TLESR; esophageal pressure topography; esophagogastric junction; herpes simplex virus 1; integrated relaxation pressure; lower esophageal sphincter; transient lower esophageal sphincter relaxation.

Conflict of interest statement

Conflicts of interest

The authors disclose no conflicts.

Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Figures

Figure 1
Figure 1
Averaged pressure topography plot of peristalsis created by superimposing 10 successive swallows of a single healthy subject to illustrate the stereotypic features of peristalsis. The peristaltic contraction is composed of 3 contractile segments (S1, S2, and S3) and the LES contraction separated by 3 relative pressure troughs: proximal (P), middle (M), and distal (D). The latency of contraction at each esophageal locus is a function of centrally mediated deglutitive inhibition (1) persisting for the duration of the S1, centrally programmed contraction and (2) the balance of postganglionic excitation (depolarization) and inhibition (hyperpolarization) from cholinergic and nitrergic myenteric neurons, respectively. LES relaxation (3) is a function of the same myenteric plexus influences, albeit in this case superimposed on a resting myogenic contraction not present in the remainder of the esophagus.
Figure 2
Figure 2
With the adoption of HRM and EPT, 3 distinct subtypes of achalasia were defined using pressure topography metrics. All have impaired EGJ relaxation and absent peristalsis, but the differentiating features are in the patterns of esophageal pressurization; type I has 100% failed peristalsis (aperistalsis), type II exhibits panesophageal pressurization ≥30 mm Hg in ≥20% swallows, and type III exhibits 2 or more premature (spastic) contractions. Note that the impedance data in the type II patient (purple overlay) indicates fluid retention in the esophagus. D is from a patient who did not meet the criterion of absent peristalsis but clearly shows impaired EGJ relaxation with segmental pressurization between the peristaltic contraction and the EGJ; hence, EGJ outflow obstruction was diagnosed. The differentiation between a spastic contraction and segmental pressurization is evident from the spatial pressure variation (SPV) plots to the right of C and D, indicating the top-to-bottom intraluminal pressure profile at the time of the black vertical dotted line. With segmental pressurization, the bolus is trapped between high-pressure zones. The patient in D was treated with a Heller myotomy with relief of dysphagia. Her postmyotomy study showed weak peristalsis. Several recent reports have shown differences in the prognostic value of these achalasia subtypes, supporting the classification scheme
Figure 3
Figure 3
Proposed model of immunotoxicity patterns leading to distinct achalasia phenotypes. Although other possibilities have been proposed, the model assumes that spastic achalasia is an immune-mediated functional aberration that is not part of the progression to aganglionosis. It is also proposed that the specifics of the antibody response vary among patients and may participate in the cytotoxic attack and/or result in cytokine-mediated alterations in neuron function. The pathogenesis of muscle hypertrophy is unknown, but this is consistently observed to accompany hypercontractility.
Figure 4
Figure 4
Incomplete TLESR in a patient with type III achalasia. Similar to patients without achalasia, patients with achalasia frequently exhibit TLESR in the course of a manometry protocol after performing a series of swallows in the supine position and then sitting up. In the case of achalasia, the resultant motor response, shown in this figure, contains all elements of a TLESR (prolonged esophageal shortening with concomitant inhibition of the crural diaphragm and strong after-contraction) except LES relaxation. In fact, the LES paradoxically contracts, consistent with the hypothesis that type III achalasia is a consequence of immune-mediated dysregulation of postganglionic inhibitory nerve function, often with an accentuation of excitatory postganglionic nerve function.
Figure 5
Figure 5
A patient with type II achalasia before and after laparoscopic Heller myotomy. After myotomy, a remnant of peristalsis with normal latency and likely extending to the proximal margin of the myotomy is clearly evident. This is a weak contraction based on the large break in the isobaric contour (IBC) between the first and second segments.

References

    1. Lendrum FC. Anatomic features of the cardiac orifice of the stomach with special reference to cardiospasm. Arch Intern Med. 1937;59:474–451.
    1. Pandolfino JE, Kahrilas PJ. The second American Gastroenterological Association technical review on the clinical use of esophageal manometry. Gastroenterology. 2005;128:209–229.
    1. Pandolfino JE, Kahrilas PJ. American Gastroenterological Association medical position statement: clinical use of esophageal manometry. Gastroenterology. 2005;128:207–208.
    1. Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago Classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24(Suppl 1):57–65.
    1. Kahrilas PJ, Kishk SM, Helm JF, et al. A comparison of pseudoachalasia and achalasia. Am J Med. 1987;82:439–446.
    1. de Oliveira RB, Rezende Filho J, Dantas RO, et al. The spectrum of esophageal motor disorders in Chagas’ disease. Am J Gastroenterol. 1995;90:1119–1124.
    1. Boeckxstaens GE. Achalasia: virus-induced euthanasia of neurons? Am J Gastroenterol. 2008;103:1610–1612.
    1. Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: a new clinically relevant classification by high-resolution manometry. Gastroenterology. 2008;135:1526–1533.
    1. Meyer GW, Austin RM, Brady CE, III, et al. Muscle anatomy of the human esophagus. J Clin Gastroenterol. 1986;8:131–134.
    1. Christensen J, Rick GA, Robison BA, et al. Arrangement of the myenteric plexus throughout the gastrointestinal tract of the opossum. Gastroenterology. 1983;85:890–899.
    1. Brasseur JG. Mechanical studies of the esophageal function. Dysphagia. 1993;8:384–386.
    1. Clouse RE, Staiano A. Topography of normal and high-amplitude esophageal peristalsis. Am J Physiol. 1993;265:G1098–G1107.
    1. Roman C, Car A. Déglutitions et contractions oesophagiennes réflexes obtenues par la stimulation des nerfs vague et laryngé supérieur. Exp Brain Res. 1970;11:48–74.
    1. Murray J, Du C, Ledlow A, et al. Nitric oxide: mediator of non-adrenergic noncholinergic responses of opossum esophageal muscle. Am J Physiol. 1991;261:G401–G406.
    1. Biancani P, Walsh JH, Behar J. Vasoactive intestinal polypeptide. A neurotransmitter for lower esophageal sphincter relaxation. J Clin Invest. 1984;73:963–967.
    1. Guelrud M, Rossiter A, Souney PF, et al. The effect of vasoactive intestinal polypeptide on the lower esophageal sphincter in achalasia. Gastroenterology. 1992;103:377–382.
    1. Kuramato H, Kadowaki M, Yoshida N. Morphological demonstration of a vagal inhibitory pathway to the lower esophageal sphincter via nitrergic neurons in the rat esophagus. Neurogastroenterol Motil. 2013;25:e485–e494.
    1. Christensen J, Fang S, Rick GA. NADPH-diaphorase-positive nerve fibers in smooth muscle layers of opossum esophagus: gradients in density. J Auton Nerv Syst. 1995;52:99–105.
    1. Crist JR, Gidda JS, Goyal RK. Intramural mechanism of esophageal peristalsis: roles of cholinergic and noncholinergic nerves. Proc Natl Acad Sci U S A. 1984;81:3595–3599.
    1. Gidda JS, Goyal RK. Regional gradient of initial inhibition and refractoriness in esophageal smooth muscle. Gastroenterology. 1985;89:843–851.
    1. Gidda JS, Goyal RK. Swallow-evoked action potentials in the vagal preganglionic efferents. J Neurophysiol. 1984;52:1169–1180.
    1. Staiano A, Clouse RE. The effects of cisapride on the topography of oesophageal peristalsis. Aliment Pharmacol Ther. 1996;10:875–882.
    1. Hellemans J, Vantrappen G, Valembois P, et al. Electrical activity of striated and smooth muscle of the esophagus. Am J Dig Dis. 1968;13:320–334.
    1. Meyer GW, Castell DO. Current concepts of esophageal function. Am J Otolaryngol. 1980;1:440–446.
    1. Ask P, Tibling L. Effect of time interval between swallows on esophageal peristalsis. Am J Physiol. 1980;238:G485.
    1. Vanek AW, Diamant NE. Responses of the human esophagus to paired swallows. Gastroenterology. 1987;92:G485.
    1. Conklin JL, Du CA, Schulze-Delrieu K, et al. Hypertrophic smooth muscle in the partially obstructed opossum esophagus. Excitability and electrophysiological properties. Gastroenterology. 1991;101:657–663.
    1. Mittal RK, Ren J, McCallum RW, Shaffer HA, Jr, et al. Modulation of feline esophageal contractions by bolus volume and outflow obstruction. Am J Physiol. 1990;258:G208–G215.
    1. Schneider JH, Peters JH, Kirkman E, et al. Are the motility abnormalities of achalasia reversible? An experimental outflow obstruction in the feline model. Surgery. 1999;125:498–503.
    1. Cruiziat C, Roman S, Robert M, et al. High-resolution esophageal manometry evaluation in symptomatic patients after gastric banding for morbid obesity. Dig Liver Dis. 2011;43:116–120.
    1. Khan A, Ren-Fielding C, Traube M. Potentially reversible pseudoachalasia after laparoscopic adjustable gastric banding. J Clin Gastroenterol. 2011;45:775–779.
    1. Gyawali CP, Kushnir VM. High-resolution manometric characteristics help differentiate types of distal esophageal obstruction in patients with peristalsis. Neurogastroenterol Motil. 2011;23:502–e197.
    1. Roman S, Pandolfino JE, Chen J, et al. Phenotypes and clinical context of hypercontractility in high resolution esophageal pressure topography (EPT) Am J Gastroenterol. 2012;107:37–45.
    1. Christensen J, Conklin JL, Freeman BW. Physiologic specialization at esophagogastric junction in three species. Am J Physiol. 1973;225:1265–1270.
    1. Goyal RK, Rattan S. Genesis of basal sphincter pressure: effect of tetrodotoxin on lower esophageal sphincter pressure in opossum in vivo. Gastroenterology. 1976;71:62–67.
    1. Asoh R, Goyal RK. Electrical activity of the opossum lower esophageal sphincter in vivo. Gastroenterology. 1978;74:835–840.
    1. Zelcer W, Weisbrodt NW. Electrical and mechanical activity of the lower esophageal sphincter in the cat. Am J Physiol. 1984;246:G243–G247.
    1. Dektor DL, Ryan JP. Transmembrane voltage of opossum esophageal smooth muscle and its response to electrical stimulation of intrinsic nerves. Gastroenterology. 1982;82:301–308.
    1. Kannan MS, Jagler LP, Daniel EE. Electrical properties of smooth muscle cell membrane of opossum esophagus. Am J Physiol. 1985;248:G342–G346.
    1. Schulze K, Hajjar JJ, Christensen J. Regional differences in potassium content of smooth muscle from opossum esophagus. Am J Physiol. 1978;235:E709–E713.
    1. Schlippert W, Schulze K, Forker EL. Calcium in smooth muscle from the opossum esophagus. Proc Soc Exp Biol Med. 1979;162:354–358.
    1. Kwiatek MA, Nicodème F, Pandolfino JE, et al. Pressure morphology of the relaxed lower esophageal sphincter: the formation and collapse of the phrenic ampulla. Am J Physiol Gastrointest Liver Physiol. 2012;302:G389–G396.
    1. Dogan I, Bhargava V, Liu J, et al. Axial stretch: a novel mechanism of the lower esophageal sphincter relaxation. Am J Physiol. 2007;292:G329–G334.
    1. Jiang Y, Bhargava V, Mittal RK. Mechanism of stretch-activated excitatory and inhibitory responses in the lower esophageal sphincter. Am J Physiol. 2009;297:G397–G405.
    1. Christensen J, Miftakhov R. Hiatus hernia: a review of evidence for its origin in esophageal longitudinal muscle dysfunction. Am J Med. 2000;108(Suppl 4a):3S–7S.
    1. Yassi R, Cheng LK, Rajagopal V, et al. Modeling of the mechanical function of the human gastroesophageal junction using an anatomically realistic three-dimensional model. J Biomech. 2009;42:1604–1609.
    1. Gonella J, Niel JP, Roman C. Vagal control of lower oesophageal sphincter motility in the cat. J Physiol. 1977;273:647–664.
    1. Dodds WJ, Dent J, Hogan WJ, et al. Effect of atropine on esophageal motor function in humans. Am J Physiol. 1981;240:G290–G296.
    1. Klein WA, Parkman HP, Dempsey DT, et al. Sphincterlike thoracoabdominal high pressure zone after esophagogastrectomy. Gastroenterology. 1993;105:1362–1369.
    1. Young RL, Page AJ, Cooper NJ, et al. Sensory and motor innervation of the crural diaphragm by the vagus nerves. Gastroenterology. 2010;138:1091–1101.
    1. Mittal RK, Rochester DF, McCallum RW. Sphincteric action of the diaphragm during a relaxed lower esophageal sphincter in humans. Am J Physiol. 1989;256:G139–G144.
    1. Mittal RK, Fisher M, McCallum RW, et al. Human lower esophageal sphincter pressure response to increased intra-abdominal pressure. Am J Physiol. 1990;258:G624–G630.
    1. De Troyer A, Sampson M, Sigrist S, et al. Action of costal and crural parts of the diaphragm on the rib cage in dog. J Appl Physiol. 1982;53:30–39.
    1. Altschuler SM, Boyle JT, Nixon TE, et al. Simultaneous reflex inhibition of lower esophageal sphincter and crural diaphragm in cats. Am J Physiol. 1985;249:G586–G591.
    1. Goyal RK, Rattan S. Nature of the vagal inhibitory innervation to the lower esophageal sphincter. J Clin Invest. 1975;55:1119–1126.
    1. Murthy KS, Zhang KM, Jin JG, et al. VIP-mediated G protein-coupled Ca2+ influx activates a constitutive NOS in dispersed gastric muscle cells. Am J Physiol. 1993;265:G660–G671.
    1. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell. 1994;78:915–918.
    1. Mittal RK, Holloway RH, Penagini R, et al. Transient lower esophageal sphincter relaxation. Gastroenterology. 1995;109:601–610.
    1. Holloway RH, Hongo M, Berger K, et al. Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology. 1985;89:779–784.
    1. Pandolfino JE, Zhang QG, Ghosh SK, et al. Transient lower esophageal sphincter relaxations and reflux: mechanistic analysis using concurrent fluoroscopy and high-resolution manometry. Gastroenterology. 2006;131:1725–1733.
    1. Babaei A, Bhargava V, Korsapati H, et al. A unique longitudinal muscle contraction pattern associated with transient lower esophageal sphincter relaxation. Gastroenterology. 2008;134:1322–1331.
    1. Pandolfino JE, Ghosh SK, Zhang Q, et al. Upper sphincter function during transient lower oesophageal sphincter relaxation (tLOSR); it is mainly about microburps. Neurogastroenterol Motil. 2007;19:203–210.
    1. Clouse RE, Staiano A. Topography of the esophageal peristaltic pressure wave. Am J Physiol. 1991;261:G677–G684.
    1. Clouse RE, Staiano A, Alrakawi A, et al. Application of topographical methods to clinical esophageal manometry. Am J Gastroenterol. 2000;95:2720–2730.
    1. Ghosh SK, Pandolfino JE, Rice J, et al. Impaired deglutitive EGJ relaxation in clinical esophageal manometry: a quantitative analysis of 400 patients and 75 controls. Am J Physiol. 2007;293:G878–G885.
    1. Staiano A, Clouse RE. Detection of incomplete lower esophageal sphincter relaxation with conventional point-pressure sensors. Am J Gastroenterol. 2001;96:3258–3267.
    1. Galey KM, Wilshire CL, Niebisch S, et al. Atypical variants of classic achalasia are common and currently under-recognized: a study of prevalence and clinical features. J Am Coll Surg. 2011;213:155–161.
    1. Hirano I, Tatum RP, Shi G, et al. Manometric heterogeneity in patients with idiopathic achalasia. Gastroenterology. 2001;120:789–798.
    1. Roman S, Kahrilas PJ, Mion F, et al. Partial recovery of peristalsis after myotomy for achalasia: more the rule than the exception. JAMA Surg. 2013;148:157–164.
    1. Dogan I, Puckett JL, Padda BS, et al. Prevalence of increased esophageal muscle thickness in patients with esophageal symptoms. Am J Gastroenterol. 2007;102:137–145.
    1. Friesen DL, Henderson RD, Hanna W. Ultrastructure of the esophageal muscle in achalasia and diffuse esophageal spasm. Am J Clin Pathol. 1983;79:319–325.
    1. Goldblum JR, Rice TW, Richter JE. Histopathologic features in esophagomyotomy specimens from patients with achalasia. Gastroenterology. 1996;111:648–654.
    1. Clark SB, Rice TW, Tubbs RR, et al. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol. 2000;24:1153–1158.
    1. Villanacci V, Annese V, Cuttitta A, et al. An immunohistochemical study of the myenteric plexus in idiopathic achalasia. Clin Gastroenterol. 2010;44:407–410.
    1. Kilic A, Krasinskas AM, Owens SR, et al. Variations in inflammation and nerve fiber loss reflect different subsets of achalasia patients. J Surg Res. 2007;143:177–182.
    1. Kilic A, Owens SR, Pennathur A, et al. An increased proportion of inflammatory cells express tumor necrosis factor alpha in idiopathic achalasia of the esophagus. Dis Esoph. 2009;22:382–385.
    1. Hoshino M, Omura N, Yano F, et al. Immunohistochemical study of the muscularis externa of the esophagus in achalasia patients. Dis Esophagus. 2013;26:14–21.
    1. De Giorgio R, Di Simone MP, Stanghellini V, et al. Esophageal and gastric nitric oxide synthesizing innervation in primary achalasia. Am J Gastroenterol. 1999;94:2357–2362.
    1. Storch WB, Eckardt VF, Junginger T. Complement components and terminal complement complex in oesophageal smooth muscle of patients with achalasia. Cell Mol Biol. 2002;48:247–252.
    1. Tøttrup A, Fredens K, Funch-Jensen P, et al. Eosinophil infiltration in primary esophageal achalasia. A possible pathogenic role. Dig Dis Sci. 1989;34:1894–1899.
    1. Savarino E, Gemignani L, Zentilin P, et al. Achalasia with dense eosinophilic infiltrate responds to steroid therapy. Clin Gastroenterol Hepatol. 2011;9:1104–1106.
    1. Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C, et al. Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci. 2002;47:15–19.
    1. Moses PL, Ellis LM, Anees MR, et al. Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease. Gut. 2003;52:629–636.
    1. Lennon VA, Sas DF, Busk MF, et al. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology. 1991;100:137–142.
    1. Lee HR, Lennon VA, Camilleri M, et al. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol. 2001;96:373–379.
    1. Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology. 2013;144:718–725.
    1. Bruley des Varannes S, Chevalier J, Pimont S, et al. Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus. Gut. 2006;55:319–326.
    1. Kim HS, Park H, Lim JH, et al. Morphometric evaluation of oesophageal wall in patients with nutcracker oesophagus and ineffective oesophageal motility. Neurogastroenterol Motil. 2008;20:869–876.
    1. Paterson WG, Beck IT, Da Costa LR. Transition from nutcracker esophagus to achalasia. A case report. J Clin Gastroenterol. 1991;13:554–558.
    1. Fontes LH, Herbella FA, Rodriguez TN, et al. Progression of diffuse esophageal spasm to achalasia: incidence and predictive factors. Dis Esophagus. 2013;26:470–474.
    1. Khatami SS, Khandwala F, Shay SS, et al. Does diffuse esophageal spasm progress to achalasia? A prospective cohort study. Dig Dis Sci. 2005;50:1605–1610.
    1. Storch WB, Eckardt VF, Wienbeck M, et al. Autoantibodies to Auerbach’s plexus in achalasia. Cell Mol Biol. 1995;41:1033–1038.
    1. Facco M, Brun P, Baesso I, et al. T cells in the myenteric plexus of achalasia patients show a skewed TCR repertoire and react to HSV-1 antigens. Am J Gastroenterol. 2008;103:1598–1609.
    1. Birgisson S, Galinski MS, Goldblum JR, et al. Achalasia is not associated with measles or known herpes and human papilloma viruses. Dig Dis Sci. 1997;42:300–306.
    1. Niwamoto H, Okamoto E, Fujimoto J, et al. Are human herpes viruses or measles virus associated with esophageal achalasia? Dig Dis Sci. 1995;40:859–864.
    1. Robertson CS, Martin BA, Atkinson M. Varicella-zoster virus DNA in the oesophageal myenteric plexus in achalasia. Gut. 1993;34:299–302.
    1. Castagliuolo I, Brun P, Costantini M, et al. Esophageal achalasia: is the herpes simplex virus really innocent? J Gastrointest Surg. 2004;8:24–30.
    1. Wattchow DA, Costa M. Distribution of peptide-containing nerve fibres in achalasia of the oesophagus. J Gastroenterol Hepatol. 1996;11:478–485.
    1. Gaumnitz EA, Bass P, Osinski MA, et al. Electrophysiological and pharmacological responses of chronically denervated lower esophageal sphincter of the opossum. Gastroenterology. 1995;109:789–799.
    1. Kushnir V, Sayuk GS, Gyawali CP. Multiple rapid swallow responses segregate achalasia subtypes on high-resolution manometry. Neurogastroenterol Motil. 2012;24:1069–e561.
    1. Savojardo D, Mangano M, Cantù P, et al. Multiple rapid swallowing in idiopathic achalasia; evidence for patients’ heterogeneity. Neurogastroenterol Motil. 2008;19:263–269.
    1. Goldblum JR, Whyte RI, Orringer MB, et al. Achalasia. A morphologic study of 42 resected specimens. Am J Surg Pathol. 1994;18:327–337.
    1. Csendes A, Smok G, Braghetto I, et al. Gastroesophageal sphincter pressure and histological changes in distal esophagus in patients with achalasia of the esophagus. Dig Dis Sci. 1985;30:941–945.
    1. Hong SJ, Bhargava V, Jiang Y, et al. A unique esophageal motor pattern that involves longitudinal muscles is responsible for emptying in achalasia esophagus. Gastroenterology. 2010;139:102–111.
    1. Mittal RK, Hong SJ, Bhargava V. Longitudinal muscle dysfunction in achalasia and its relevance. J Neurogastroenterol Motil. 2013;19:126–136.
    1. Kwiatek KA, Post J, Pandolfino JE, et al. Transient lower esophageal sphincter relaxation in achalasia: everything but LES relaxation. Neurogastroenterol Mot. 2009;21:1250–1255.
    1. Parrilla P, Martinez de Haro LF, et al. Factors involved in the return of peristalsis in patients with achalasia of the cardia after Heller’s myotomy. Am J Gastroenterol. 1995;90:713–717.
    1. Zaninotto G, Costantini M, Anselmino M, et al. Onset of oesophageal peristalsis after surgery for idiopathic achalasia. Br J Surg. 1995;82:1532–1534.
    1. Tatum RP, Wong JA, Figueredo EJ, et al. Return of esophageal function after treatment for achalasia as determined by imped-ance-manometry. J Gastrointest Surg. 2007;11:1403–1409.
    1. Nicodème F, Ruigh A, Xiao Y, et al. A comparison of symptom severity and bolus retention to Chicago Classification esophageal topography metrics in achalasia. Clin Gastroenterol Hepatol. 2013;11:131–137.
    1. Metzger M, Caldwell C, Barlow AJ, et al. Enteric nervous system stem cells derived from human gut mucosa for the treatment of aganglionic gut disorders. Gastroenterology. 2009;136:2214–2225.
    1. Kulkarni S, Becker L, Pasricha JP. Stem cell transplantation in neurodegenerative disorders of the gastrointestinal tract: future or fiction? Gut. 2012;61:613–621.

Source: PubMed

3
Subskrybuj